Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

AMPfret: synthetic nanosensor for cellular energy states.

Crocker H, Pelosse M, Schlattner U, Berger I.

Biochem Soc Trans. 2020 Feb 3. pii: BST20190347. doi: 10.1042/BST20190347. [Epub ahead of print]

PMID:
32010945
2.

Withdrawal: Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo : Role of mitochondrial reactive nitrogen species.

Zou MH, Kirkpatrick SS, Davis BJ, Nelson JS, Wiles WG 4th, Schlattner U, Neumann D, Brownlee M, Freeman MB, Goldman MH.

J Biol Chem. 2019 Sep 6;294(36):13525. doi: 10.1074/jbc.W119.010595. No abstract available.

3.

LKB1 specifies neural crest cell fates through pyruvate-alanine cycling.

Radu AG, Torch S, Fauvelle F, Pernet-Gallay K, Lucas A, Blervaque R, Delmas V, Schlattner U, Lafanechère L, Hainaut P, Tricaud N, Pingault V, Bondurand N, Bardeesy N, Larue L, Thibert C, Billaud M.

Sci Adv. 2019 Jul 17;5(7):eaau5106. doi: 10.1126/sciadv.aau5106. eCollection 2019 Jul.

4.

Citrulline stimulates muscle protein synthesis, by reallocating ATP consumption to muscle protein synthesis.

Goron A, Lamarche F, Blanchet S, Delangle P, Schlattner U, Fontaine E, Moinard C.

J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):919-928. doi: 10.1002/jcsm.12435. Epub 2019 May 8.

5.

Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2 O2 emission during impaired oxidative phosphorylation.

Hughes MC, Ramos SV, Turnbull PC, Rebalka IA, Cao A, Monaco CMF, Varah NE, Edgett BA, Huber JS, Tadi P, Delfinis LJ, Schlattner U, Simpson JA, Hawke TJ, Perry CGR.

J Cachexia Sarcopenia Muscle. 2019 Jun;10(3):643-661. doi: 10.1002/jcsm.12405. Epub 2019 Apr 2.

6.

Synthetic energy sensor AMPfret deciphers adenylate-dependent AMPK activation mechanism.

Pelosse M, Cottet-Rousselle C, Bidan CM, Dupont A, Gupta K, Berger I, Schlattner U.

Nat Commun. 2019 Mar 4;10(1):1038. doi: 10.1038/s41467-019-08938-z.

7.

Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy.

Hughes MC, Ramos SV, Turnbull PC, Edgett BA, Huber JS, Polidovitch N, Schlattner U, Backx PH, Simpson JA, Perry CGR.

J Physiol. 2019 Jan 23. doi: 10.1113/JP277306. [Epub ahead of print]

8.

Proteolipid domains form in biomimetic and cardiac mitochondrial vesicles and are regulated by cardiolipin concentration but not monolyso-cardiolipin.

Pennington ER, Sullivan EM, Fix A, Dadoo S, Zeczycki TN, DeSantis A, Schlattner U, Coleman RA, Chicco AJ, Brown DA, Shaikh SR.

J Biol Chem. 2018 Oct 12;293(41):15933-15946. doi: 10.1074/jbc.RA118.004948. Epub 2018 Aug 29.

9.

Inhibition of BET Proteins Reduces Right Ventricle Hypertrophy and Pulmonary Hypertension Resulting from Combined Hypoxia and Pulmonary Inflammation.

Chabert C, Khochbin S, Rousseaux S, Veyrenc S, Furze R, Smithers N, Prinjha RK, Schlattner U, Pison C, Dubouchaud H.

Int J Mol Sci. 2018 Jul 30;19(8). pii: E2224. doi: 10.3390/ijms19082224.

10.

The mitochondrial nucleoside diphosphate kinase (NDPK-D/NME4), a moonlighting protein for cell homeostasis.

Lacombe ML, Tokarska-Schlattner M, Boissan M, Schlattner U.

Lab Invest. 2018 May;98(5):582-588. doi: 10.1038/s41374-017-0004-5. Epub 2018 Feb 28. Review.

11.

Mitochondrial Proteolipid Complexes of Creatine Kinase.

Schlattner U, Kay L, Tokarska-Schlattner M.

Subcell Biochem. 2018;87:365-408. doi: 10.1007/978-981-10-7757-9_13. Review.

PMID:
29464567
12.

The NDPK/NME superfamily: state of the art.

Boissan M, Schlattner U, Lacombe ML.

Lab Invest. 2018 Feb;98(2):164-174. doi: 10.1038/labinvest.2017.137.

13.

NME4/nucleoside diphosphate kinase D in cardiolipin signaling and mitophagy.

Schlattner U, Tokarska-Schlattner M, Epand RM, Boissan M, Lacombe ML, Kagan VE.

Lab Invest. 2018 Feb;98(2):228-232. doi: 10.1038/labinvest.2017.113. Epub 2017 Oct 16. Review.

14.

Muscle hypertrophy in hypoxia with inflammation is controlled by bromodomain and extra-terminal domain proteins.

Chabert C, Khochbin S, Rousseaux S, Furze R, Smithers N, Prinjha R, Schlattner U, Pison C, Dubouchaud H.

Sci Rep. 2017 Sep 21;7(1):12133. doi: 10.1038/s41598-017-12112-0.

15.

Cell-Free Protein Synthesis Enhancement from Real-Time NMR Metabolite Kinetics: Redirecting Energy Fluxes in Hybrid RRL Systems.

Panthu B, Ohlmann T, Perrier J, Schlattner U, Jalinot P, Elena-Herrmann B, Rautureau GJP.

ACS Synth Biol. 2018 Jan 19;7(1):218-226. doi: 10.1021/acssynbio.7b00280. Epub 2017 Oct 2.

PMID:
28915016
16.

The advantage of channeling nucleotides for very processive functions.

Zala D, Schlattner U, Desvignes T, Bobe J, Roux A, Chavrier P, Boissan M.

Version 2. F1000Res. 2017 May 18 [revised 2017 Jan 1];6:724. doi: 10.12688/f1000research.11561.2. eCollection 2017. Review.

17.

Creatine kinase in human erythrocytes: A genetic anomaly reveals presence of soluble brain-type isoform.

Kay L, Tokarska-Schlattner M, Quenot-Carrias B, Goudet B, Bugert P, Arnold H, Scheuerbrandt G, Schlattner U.

Blood Cells Mol Dis. 2017 May;64:33-37. doi: 10.1016/j.bcmd.2017.03.008. Epub 2017 Mar 18.

PMID:
28364583
18.

Simple oxygraphic analysis for the presence of adenylate kinase 1 and 2 in normal and tumor cells.

Klepinin A, Ounpuu L, Guzun R, Chekulayev V, Timohhina N, Tepp K, Shevchuk I, Schlattner U, Kaambre T.

J Bioenerg Biomembr. 2016 Oct;48(5):531-548. Epub 2016 Nov 17.

PMID:
27854030
19.

Genetically Encoded Fluorescent Biosensors to Explore AMPK Signaling and Energy Metabolism.

Pelosse M, Cottet-Rousselle C, Grichine A, Berger I, Schlattner U.

Exp Suppl. 2016;107:491-523. Review.

PMID:
27812993
20.

Cellular compartmentation of energy metabolism: creatine kinase microcompartments and recruitment of B-type creatine kinase to specific subcellular sites.

Schlattner U, Klaus A, Ramirez Rios S, Guzun R, Kay L, Tokarska-Schlattner M.

Amino Acids. 2016 Aug;48(8):1751-74. doi: 10.1007/s00726-016-2267-3. Epub 2016 Jun 18. Review.

PMID:
27318991

Supplemental Content

Loading ...
Support Center